Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

被引：0

作者：

Vittayawacharin, Pongthep ^{[1
,2
]}

Jeyakumar, Deepa ^{[1
]}

Lee, Benjamin J. ^{[3
]}

Doh, Jean ^{[3
]}

Griffin, Shawn ^{[4
]}

Van Etten, Richard A. ^{[1
]}

Kongtim, Piyanuch ^{[1
]}

Ciurea, Stefan ^{[1
]}

机构：

[1] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Hematopoiet Stem Cell Transplantat & Cellular The, Orange, CA USA

[2] Mahidol Univ, Siriraj Hosp, Fac Med, Div Hematol,Dept Med, Bangkok, Thailand

[3] Univ Calif Irvine, Dept Pharm, Orange, CA USA

[4] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm Practice, Orange, CA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190530

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
Lopez, F
Parker, P
Nademanee, A
Rodriguez, RT
Al-Kadbimi, Z
Bhatia, R
Cohen, S
Falk, P
Fung, H
Kirschbaum, M
Krishnan, A
Kogut, N
Molina, A
Nakamura, R
O'Donnell, M
Popplewell, L
Pullarkat, V
Rosenthal, P
Sahebi, F
Smith, E
Snyder, D
Somlo, G
Spielberger, R
Stein, A
Sweetman, R
Zain, J
Forman, S
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) : 307 - 313
[22] Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
Sharma, Nidhi
Zhao, Qiuhong
Ni, Bin
Elder, Patrick
Puto, Marcin
Benson, Don M.
Rosko, Ashley
Chaudhry, Maria
Devarakonda, Srinivas
Bumma, Naresh
Khan, Abdullah
Vasu, Sumithira
Jaglowski, Samantha
William, Basem M.
Mims, Alice
Choe, Hannah
Larkin, Karilyn
Brammer, Jonathan
Wall, Sarah
Grieselhuber, Nicole
Saad, Ayman
Penza, Sam
Efebera, Yvonne
CANCERS, 2021, 13 (04) : 1 - 16
[23] Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
Mehta, Rohtesh S.
Saliba, Rima M.
Hayase, Eiko
Jenq, Robert R.
Abraham, Susan
Rashid, Asif
Rondon, Gabriela
Al-Atrash, Gheath
Bashir, Qaiser
Hosing, Chitra M.
Kebriaei, Partow
Khouri, Issa
Marin, David
Nieto, Yago
Olson, Amanda
Oran, Betul
Popat, Uday R.
Qazilbash, Muzaffar H.
Ramdial, Jeremy
Srour, Samer
Champlin, Richard E.
Rezvani, Katayoun
Shpall, Elizabeth J.
Alousi, Amin M.
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08): : 500.e1 - 500.e10
[24] Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
Hamilton, Betty K.
Rybicki, Lisa A.
Li, Hong
Lucas, Taylor
Corrigan, Donna
Kalaycio, Matt
Sobecks, Ronald
Hanna, Rabi
Rotz, Seth J.
Dean, Robert M.
Gerds, Aaron T.
Jagadeesh, Deepa
Brunstein, Claudio
Sauter, Craig S.
Copelan, Edward A.
Majhail, Navneet S.
BLOOD ADVANCES, 2023, 7 (16) : 4505 - 4513
[25] Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis
Castagna, Luca
Mussetti, Alberto
Devillier, Raynier
Dominietto, Alida
Marcatti, Magda
Milone, Giuseppe
Maura, Francesco
de Philippis, Chiara
Bruno, Benedetto
Furst, Sabine
Blaise, Didier
Corradini, Paolo
Montefusco, Vittorio
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1549 - 1554
[26] A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis
Perkins, Janelle
Field, Teresa
Kim, Jongphil
Kharfan-Dabaja, Mohamed A.
Fernandez, Hugo
Ayala, Ernesto
Perez, Lia
Xu, Mian
Alsina, Melissa
Ochoa, Leonel
Sullivan, Daniel
Janssen, William
Anasetti, Claudio
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (07) : 937 - 947
[27] Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations
Salas, Maria Queralt
Pedraza, Alexandra
Charry, Paola
Suarez-Lledo, Maria
Rodriguez-Lobato, Luis Gerardo
Brusosa, Marc
Solano, Maria Teresa
Serrahima, Anna
Nomdedeu, Meritxell
Cid, Joan
Lozano, Miquel
Arcarons, Jordi
de Llobet, Noemi
Rosinol, Laura
Esteve, Jordi
Urbano-Ispizua, Alvaro
Carreras, Enric
Fernandez-Aviles, Francesc
Rovira, Montserrat
Martinez, Carmen
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : 213.e1 - 213.e12
[28] MULTICENTER RANDOMIZED PHASE II CLINICAL TRIAL TO COMPARE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL VERSUS RUXOLITINIB AFTER POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCYRUXO)
Moiseev, Ivan
Kitaeva, Yulia
Drokov, Mikhail
Rudakova, Tatyana
Barabanshikova, Maria
Afanasyeva, Ksenia
Morozova, Elena
Vlasova, Yulia
Popova, Natalya
Sveshnikova, Yulia
Vasilyeva, Vera
Kuzmina, Larisa
Bondarenko, Sergey
Konstantinova, Tatyana
Parovichnikova, Elena
Kulagin, Alexander
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 280 - 281
[29] Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation
Miekarek, Marco
Furlong, Terry
O'Donnell, Paul V.
Storer, Barry E.
McCune, Jeannine S.
Storb, Rainer F.
Carpenter, Paul A.
Flowers, Mary E. D.
Appelbaum, Frederick R.
Martin, Paul J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S406 - S406
[30] Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
Lin, Andrew
Flynn, Jessica
DeRespiris, Lauren
Figgins, Bradley
Griffin, Meagan
Lau, Carmen
Proli, Anthony
Devlin, Sean M.
Cho, Christina
Tamari, Roni
Jakubowski, Ann A.
Papadopoulos, Esperanza B.
Giralt, Sergio A.
Perales, Miguel-Angel
Seo, Susan K.
Shaffer, Brian
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):

← 1 2 3 4 5 →